Your browser doesn't support javascript.
loading
Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma.
Burmakin, Mikhail; van Wieringen, Tijs; Olsson, P Olof; Stuhr, Linda; Åhgren, Aive; Heldin, Carl-Henrik; Reed, Rolf K; Rubin, Kristofer; Hellberg, Carina.
Affiliation
  • Burmakin M; Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, 751 24, Uppsala, Sweden.
  • van Wieringen T; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77, Stockholm, Sweden.
  • Olsson PO; Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, 751 24, Uppsala, Sweden.
  • Stuhr L; School of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK.
  • Åhgren A; Department of Laboratory Medicine, Medicon Village, Lund University, 223 63, Lund, Sweden.
  • Heldin CH; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Reed RK; Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, 751 24, Uppsala, Sweden.
  • Rubin K; Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, 751 24, Uppsala, Sweden.
  • Hellberg C; Department of Biomedicine, University of Bergen, Bergen, Norway.
J Transl Med ; 15(1): 47, 2017 02 23.
Article in En | MEDLINE | ID: mdl-28231806
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxygen / Colonic Neoplasms / Extracellular Matrix / Imatinib Mesylate / Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Transl Med Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxygen / Colonic Neoplasms / Extracellular Matrix / Imatinib Mesylate / Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Transl Med Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United kingdom